Sera Prognostics SERA
NASDAQ SERA
$2.07 +0.08 (+4.02%)
As of: Aug 20, 2026 · 3:59 PM EDT

Sera Prognostics (SERA) Total Debt (2020)

Sera Prognostics' (SERA) quarterly Total Debt came in at $4.7 million in Q4 2020.

Sera Prognostics (SERA) Total Debt (2020) Analysis & Trends

Sera Prognostics (SERA) has 1 years of Total Debt data on file, last reported at $4.7 million in Q4 2020.

  • Quarterly Total Debt changed N/A year-over-year to $4.7 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $4.7 million (changed N/A YoY) and the FY2020 annual result came in at $4.7 million, changed N/A from the prior year.
  • Total Debt was little changed at $4.7 million in Q4 2020.
  • In the past five years, Total Debt ranged from a high of $4.7 million in Q4 2020 to a low of $4.7 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 32.61 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 14.94 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 12.62 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 10.10 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 8.68 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 1.89 Bn
10 Sera Prognostics 103.48 Mn 103.48 Mn -20,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2020 4.70 Mn